Citation 90498

PHRUTIVORAPONGKUL,A: LIPIPUN,V: RUANGRUNGSI,N: KIRTIKARA,K: NISHIKAWA,K: MARUYAMA,S: WATANABE,T: ISHIKAWA,T:. (2003). STUDIES ON THE CHEMICAL CONSTITUENTS OF STEM BARK OF MILLETTIA LEUCANTHA: ISOLATION OF NEW CHALCONES WITH CYTOTOXIC, ANTI-HERPES SIMPLEX VIRUS AND ANTI-INFLAMMATORY ACTIVITIES.. 51(2)

Citation Details

Title	STUDIES ON THE CHEMICAL CONSTITUENTS OF STEM BARK OF MILLETTIA LEUCANTHA: ISOLATION OF NEW CHALCONES WITH CYTOTOXIC, ANTI-HERPES SIMPLEX VIRUS AND ANTI-INFLAMMATORY ACTIVITIES.
Authors	PHRUTIVORAPONGKUL,A: LIPIPUN,V: RUANGRUNGSI,N: KIRTIKARA,K: NISHIKAWA,K: MARUYAMA,S: WATANABE,T: ISHIKAWA,T:
Year	2003
Volume	51
Issue	2

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Millettia leucantha (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHALCONE,2'-4'-DIMETHOXY-3-4-METHYLENEDIOXY:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-DIMETHOXY-3-4-METHYLENEDIOXY:	WEAK ACTIVITY
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-DIMETHOXY-3-4-METHYLENEDIOXY:	INACTIVE
4	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-DIMETHOXY-3-4-METHYLENEDIOXY:	INACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHALCONE,2'-HYDROXY-3-4-4'-6-TETRAMETHOXY:	None
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY-3-4-4'-6-TETRAMETHOXY:	INACTIVE
7	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY-3-4-4'-6-TETRAMETHOXY:	INACTIVE
8	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY-3-4-4'-6-TETRAMETHOXY:	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KARANJIN	None
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHALCONE,DIHYDRO: 2'-4'-6'-TRIMETHOXY-3-4-METHYLENEDIOXY:	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,DIHYDRO: 2'-4'-6'-TRIMETHOXY-3-4-METHYLENEDIOXY:	INACTIVE
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,DIHYDRO: 2'-4'-6'-TRIMETHOXY-3-4-METHYLENEDIOXY:	ACTIVE
13	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,DIHYDRO: 2'-4'-6'-TRIMETHOXY-3-4-METHYLENEDIOXY:	ACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LANCEOLATIN B	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LANCEOLATIN B	INACTIVE
16	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LANCEOLATIN B	INACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MILLETENONE,DIHYDRO: METHYL ETHER	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MILLETENONE,DIHYDRO: METHYL ETHER	INACTIVE
19	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MILLETENONE,DIHYDRO: METHYL ETHER	ACTIVE
20	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MILLETENONE,DIHYDRO: METHYL ETHER	ACTIVE
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHALCONE,2-4-6-BETA-TETRAMETHOXY-3'-4'-METHYLENEDIOXY:	None
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2-4-6-BETA-TETRAMETHOXY-3'-4'-METHYLENEDIOXY:	INACTIVE
23	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2-4-6-BETA-TETRAMETHOXY-3'-4'-METHYLENEDIOXY:	INACTIVE
24	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2-4-6-BETA-TETRAMETHOXY-3'-4'-METHYLENEDIOXY:	INACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KANUGIN,DEMETHOXY:	None
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KANUGIN,DEMETHOXY:	INACTIVE
27	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KANUGIN,DEMETHOXY:	INACTIVE
28	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KANUGIN,DEMETHOXY:	INACTIVE
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVONE,3'-4'-METHYLENEDIOXY-7-METHOXY:	None
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-METHYLENEDIOXY-7-METHOXY:	INACTIVE
31	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-METHYLENEDIOXY-7-METHOXY:	INACTIVE
32	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-METHYLENEDIOXY-7-METHOXY:	ACTIVE
33	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CHALCONE,2'-4'-6'-TRIMETHXOY-3-4-METHYLENEDIOXY:	None
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-6'-TRIMETHXOY-3-4-METHYLENEDIOXY:	ACTIVE
35	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-6'-TRIMETHXOY-3-4-METHYLENEDIOXY:	INACTIVE
36	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-6'-TRIMETHXOY-3-4-METHYLENEDIOXY:	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVONE,3'-4'-METHYLENEDIOXY-5-7-DIMETHOXY:	None
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-METHYLENEDIOXY-5-7-DIMETHOXY:	INACTIVE
39	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-METHYLENEDIOXY-5-7-DIMETHOXY:	INACTIVE
40	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-METHYLENEDIOXY-5-7-DIMETHOXY:	INACTIVE

Citation 90498

Citation Details

Summary

Organisms and Their Experiments (1)

Millettia leucantha (FABACEAE)

Show SPARQL Queries (1)

Query 1